HOME >> MEDICINE >> NEWS
Children's Hospital Oakland opens new $5.6 million infectious disease lab

a few blocks north of the hospital. This new unit consists of interactive laboratories and office spaces, as well as specialized, shared facilities such as a DNA clean room and a biological safety level-3 facility (BL-3), which is one of the highest safety and security standards for this type of medical research.

"The CIVD's BL-3 status means that when we constructed this laboratory we had to meet some of the highest safety standards established by the National Institutes of Health (NIH) and the Center for Disease Control and Prevention (CDC)," said Alex Lucas, Ph.D., deputy director of CHORI. "The end result is that we are better equipped to expand our research capabilities to design and improve vaccines in ways we never could before."

CHORI was awarded a $2 million construction grant from the National Center for Research Resources (NCRR) at the NIH to build the CIVD. Dr. Lucas was the principal investigator on this grant. The remaining funds were secured through individual donations and large financial gifts from the philanthropic community.

CHORI's operating budget in 2005 is $48 million, which is generated through extramural grants obtained by scientists and clinicians. The awards CHORI scientists received placed CHORI 14th out of 113 children's hospitals and pediatric departments in the United States, according to data provided by The National Association of Children's Hospitals in their most recent survey.


'"/>

Contact: Venita Robinson
vrobinson@mail.cho.org
510-428-3069
Children's Hospital & Research Center at Oakland
3-Feb-2005


Page: 1 2

Related medicine news :

1. Sleeping Through the Night: Childrens sleep expert advises parents
2. Surgeon General at Childrens Hospital & Research Center at Oakland
3. Brenner Childrens Hospital named to NIH Pediatric Heart Network
4. Childrens Hospital at Vanderbilt ranked 8th in nation by Child magazine
5. Childrens anxiety prior to surgery linked to behavioral changes
6. Texas Childrens Hospital specialists say proactive approach best defense against flu season
7. Texas Childrens Hospital jumps up in list of Americas Best
8. NIH awards Baylor, Texas Childrens No. 1 spot in pediatric-research funding
9. Researchers at Cincinnati Childrens link a strain of E. coli to diarrhea in children
10. Texas Childrens Hospital implants first MicroMed/DeBakey child ventricular assist device
11. Childrens genetic factors determine HIV progression according to UCSD study

Post Your Comments:
(Date:8/27/2014)... Time to Play Golf, a fast-growing ... , With 80-degree temperatures and only partially clouded skies, ... (TTPGolf) Inaugural Outing. Around 50 golfers showed up to duel ... beautiful Heron Glen Golf Course in Ringoes, New Jersey. , ... to be having a great time. Birdies were dropping and ...
(Date:8/27/2014)... PCOS (Polycystic Ovarian Syndrome) affects an estimated 1 ... a number of health disorders and medical conditions. However, ... within the medical community. Many women are suffering from ... body fat around the waist area (truncal obesity), but ... by PCOS. , Awareness is the first step to ...
(Date:8/27/2014)... August 27, 2014 The Connecticut Community for ... on September 19, 2014, from 10:00 AM – 2:00 PM ... turn out from participants across the state to show their ... front of Connecticut’s state capitol. , Recovery Walks! is a ... addiction to alcohol and other drugs as well as their ...
(Date:8/26/2014)... Recently, BambooIndustry.com, the popular online supplier of bamboo ... floorings for the online market. Along with that, ... the new items are offered at greatly discounted prices, ... will end on September 10, 2014. , At ... with low shipping costs. The company wants to offer ...
(Date:8/26/2014)... In its latest blog post, Best ... that having family close by during a stay in ... not the process is successful, is looking at 6 ... people need medication to help them overcome addiction, particularly ... triggers like anxiety and depression, many others will be ...
Breaking Medicine News(10 mins):Health News:Recap: Time To Play Golf Inaugural Golf Outing 2Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 2Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 3Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 4Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 5Health News:The CT Community for Addiction Recovery to Proudly Host 15th Annual Recovery Walks! 2Health News:Discounted, High Quality Bamboo Floorings Provided Online By BambooIndustry.com 2Health News:Latest Best Drug Rehabilitation Blog Post Looks at 6 Ways to Beat Addiction with Medication 2Health News:Latest Best Drug Rehabilitation Blog Post Looks at 6 Ways to Beat Addiction with Medication 3
(Date:8/26/2014)... SynCardia Systems, Inc., manufacturer of the SynCardia ... 5000 named by the business magazine Inc. ... Canada and CE approved Total Artificial Heart, which is ... transplant," says Michael P. Garippa , SynCardia,s CEO ... for patients dying from end-stage biventricular heart failure." ...
(Date:8/26/2014)... ALISO VIEJO, Calif. , Aug. 26, 2014 ... ) today announced the enrollment of the first ... the efficacy, safety and tolerability of AVP-786 for ... AVP-786 is a novel investigational drug consisting of ... dose quinidine. "There are millions of ...
(Date:8/26/2014)... and LONDON , August 26, 2014 ... FDNA Inc. ( http://www.fdna.com ) and London Medical Databases ... partnered to offer, for the first time, online access ... FDNA, developer of the Facial Dysmorphology ... collection into Face2Gene [ TM ] , ...
Breaking Medicine Technology:Inc. Magazine Ranks SynCardia Systems in Top 3rd in its 2014 Inc. 5000 List 2Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 2Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 3Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 4Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 5Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 6FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 2FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 3
Cached News: